{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:50:19Z","timestamp":1781844619977,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ncl.2025.05.016","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T19:27:34Z","timestamp":1752866854000},"page":"837-849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acquired and Genetic Amyloid Neuropathies"],"prefix":"10.1016","volume":"43","author":[{"given":"Chafic","family":"Karam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamatha","family":"Pasnoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Barohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen M.","family":"Dimachkie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2025.05.016_bib1","unstructured":"Schwann T. Archiv F\u00fcr Anatomie, Physiologie Und Wissenschaftliche Medicin. 1836."},{"key":"10.1016\/j.ncl.2025.05.016_bib2","series-title":"Die Cellularpathologie in Ihrer Begr\u00fcndung Auf Physiologische Und Pathologische Gewebelehre: Zwanzig Vorlesungen, Gehalten W\u00e4hrend der monate Februar, M\u00e4rz Und April 1858 Im Pathologischen Institute Zu Berlin","author":"Virchow","year":"2018"},{"issue":"3","key":"10.1016\/j.ncl.2025.05.016_bib3","first-page":"111","article-title":"The staining of amyloid with Congo red","volume":"3","author":"Scott","year":"1922","journal-title":"Br J Exp Pathol"},{"issue":"101","key":"10.1016\/j.ncl.2025.05.016_bib4","first-page":"77","article-title":"\u00dcber Amyloidablagerungen in den peripheren Nerven","volume":"1","author":"K\u00f6nigstein","year":"1925","journal-title":"Zeitschrift f\u00fcr die gesamte Neurologie und Psychiatrie"},{"key":"10.1016\/j.ncl.2025.05.016_bib5","first-page":"453","article-title":"Les plaques amylo\u00efdes c\u00e9r\u00e9brales dans la d\u00e9mence s\u00e9nile","volume":"42","author":"Divry","year":"1927","journal-title":"Rev Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2025.05.016_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13506129.2020.1835263","article-title":"Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"27","author":"Benson","year":"2020","journal-title":"Amyloid"},{"issue":"3","key":"10.1016\/j.ncl.2025.05.016_bib7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/brain\/75.3.408","article-title":"A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves","volume":"75","author":"Andrade","year":"1952","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.ncl.2025.05.016_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/mus.28164","article-title":"Paraproteinemic neuropathies","volume":"70","author":"Traub","year":"2024","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.ncl.2025.05.016_bib9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/archinte.1989.00390020080016","article-title":"Peripheral neuropathy as an early marker of AL amyloidosis","volume":"149","author":"Duston","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ncl.2025.05.016_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120341","article-title":"Prevalence and predictors of neurological manifestations in systemic AL amyloidosis","volume":"440","author":"Thimm","year":"2022","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.ncl.2025.05.016_bib11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0002-9343(98)00037-0","article-title":"Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy","volume":"104","author":"Rajkumar","year":"1998","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.ncl.2025.05.016_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1212\/01.wnl.0000336370.51010.a1","volume":"72","author":"England","year":"2009","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ncl.2025.05.016_bib13","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1373\/clinchem.2004.046870","article-title":"Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice","volume":"51","author":"Katzmann","year":"2005","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.ncl.2025.05.016_bib14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1529-8027.2006.00107.x","article-title":"Isolated amyloidosis presenting with lumbosacral radiculoplexopathy: description of two cases and pathogenic review","volume":"11","author":"Ladha","year":"2006","journal-title":"J Peripher Nerv Syst"},{"issue":"5","key":"10.1016\/j.ncl.2025.05.016_bib15","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/mus.21561","article-title":"Primary amyloidosis presenting as upper limb multiple mononeuropathies","volume":"41","author":"Tracy","year":"2010","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.016_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-0044-1791519","article-title":"Hereditary transthyretin amyloidosis polyneuropathy","volume":"45","author":"Qarni","year":"2025","journal-title":"Semin Neurol"},{"issue":"23","key":"10.1016\/j.ncl.2025.05.016_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033770","article-title":"Hereditary transthyretin amyloidosis in patients referred to a genetic testing program","volume":"13","author":"Bhatt","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.ncl.2025.05.016_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mus.20821","article-title":"The molecular biology and clinical features of amyloid neuropathy","volume":"36","author":"Benson","year":"2007","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.ncl.2025.05.016_bib19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10741-021-10080-2","article-title":"Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness","volume":"27","author":"Nativi-Nicolau","year":"2022","journal-title":"Heart Fail Rev"},{"issue":"9","key":"10.1016\/j.ncl.2025.05.016_bib20","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1007\/s00415-020-09899-w","article-title":"Screening for genetic mutations in patients with neuropathy without definite etiology is useful","volume":"267","author":"Vogt","year":"2020","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2025.05.016_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mus.28026","article-title":"Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the United States: recommendations from a panel of experts","volume":"69","author":"Karam","year":"2024","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.ncl.2025.05.016_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25073770","article-title":"Neurofilament light chains in systemic amyloidosis: a systematic review","volume":"25","author":"Berends","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.016_bib23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12883-023-03116-7","article-title":"The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy","volume":"23","author":"Yarlas","year":"2023","journal-title":"BMC Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2025.05.016_bib24","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/mus.27675","article-title":"Long-term treatment effects of inotersen on health-related quality of life in patients with hATTR amyloidosis with polyneuropathy: analysis of the open-label extension of the NEURO-TTR trial","volume":"66","author":"Karam","year":"2022","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.016_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13023-024-03198-7","article-title":"Treatment characteristics of patients with hereditary transthyretin amyloidosis: a cohort study","volume":"19","author":"Qarni","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ncl.2025.05.016_bib26","first-page":"1","article-title":"PRX004 in variant amyloid transthyretin (ATTRv) amyloidosis: results of a phase 1, open-label, dose-escalation study","author":"Suhr","year":"2024","journal-title":"Amyloid"},{"issue":"23","key":"10.1016\/j.ncl.2025.05.016_bib27","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa2412309","article-title":"CRISPR-Cas9 gene editing with nexiguran ziclumeran for ATTR cardiomyopathy","volume":"391","author":"Fontana","year":"2024","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ncl.2025.05.016_bib28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ncl.2025.05.016_bib29","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1212\/WNL.0000000000012965","article-title":"CNS involvement in hereditary transthyretin amyloidosis","volume":"97","author":"Sousa","year":"2021","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ncl.2025.05.016_bib30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/13506129.2022.2056011","article-title":"CSF\/plasma levels, transthyretin stabilisation and safety of multiple doses of tolcapone in subjects with hereditary ATTR amyloidosis","volume":"29","author":"Takahashi","year":"2022","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.016_bib31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s13023-024-03407-3","article-title":"The journey to diagnosis of wild-type transthyretin-mediated (ATTRwt) amyloidosis: a path with multisystem involvement","volume":"19","author":"Karam","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ncl.2025.05.016_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1345608","article-title":"Neuromuscular manifestations of wild type transthyretin amyloidosis: a review and single center\u2019s experience","volume":"11","author":"\u017divkovi\u0107","year":"2024","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.016_bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2409134","article-title":"Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy","volume":"392","author":"Fontana","year":"2025","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ncl.2025.05.016_bib34","first-page":"314","article-title":"Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome","volume":"1","author":"Meretoja","year":"1969","journal-title":"Ann Clin Res"},{"issue":"5","key":"10.1016\/j.ncl.2025.05.016_bib35","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1002\/mus.27714","article-title":"Gelsolin variant amyloidosis mimicking progressive bulbar palsy","volume":"66","author":"Park","year":"2022","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.ncl.2025.05.016_bib36","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/00007890-200104150-00026","article-title":"Clinical and biochemical outcome of hepatorenal transplantation for hereditary systemic amyloidosis associated with apolipoprotein AI Gly26Arg","volume":"71","author":"Gillmore","year":"2001","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ncl.2025.05.016_bib37","doi-asserted-by":"crossref","first-page":"omaa014","DOI":"10.1093\/omcr\/omaa014","article-title":"Unique skin manifestations of hereditary apolipoprotein A-1 amyloidosis","volume":"2020","author":"Moshe-Lilie","year":"2020","journal-title":"Oxf Med Case Reports"},{"issue":"1","key":"10.1016\/j.ncl.2025.05.016_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.kint.2020.03.033","article-title":"New clinical forms of hereditary apoA-I amyloidosis entail both glomerular and retinal amyloidosis","volume":"98","author":"Colombat","year":"2020","journal-title":"Kidney Int"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861925000350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861925000350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:20:35Z","timestamp":1761592835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861925000350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0733861925000350"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2025.05.016","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired and Genetic Amyloid Neuropathies","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2025.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}